These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2839719)

  • 1. Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains.
    Sedarati F; Javier RT; Stevens JG
    J Virol; 1988 Aug; 62(8):3037-9. PubMed ID: 2839719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.
    Nishiyama Y; Kimura H; Daikoku T
    J Virol; 1991 Aug; 65(8):4520-4. PubMed ID: 1649347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two avirulent herpes simplex viruses generate lethal recombinants in vivo.
    Javier RT; Sedarati F; Stevens JG
    Science; 1986 Nov; 234(4777):746-8. PubMed ID: 3022376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene.
    Izumi KM; Stevens JG
    J Exp Med; 1990 Aug; 172(2):487-96. PubMed ID: 2165127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS.
    Thompson RL; Cook ML; Devi-Rao GB; Wagner EK; Stevens JG
    J Virol; 1986 Apr; 58(1):203-11. PubMed ID: 3005649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness.
    Yuhasz SA; Stevens JG
    J Virol; 1993 Oct; 67(10):5948-54. PubMed ID: 8396662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
    Efstathiou S; Kemp S; Darby G; Minson AC
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, transfer, and characterization of cloned herpes simplex virus invasiveness regions.
    Goodman JL; Cook ML; Sederati F; Izumi K; Stevens JG
    J Virol; 1989 Mar; 63(3):1153-61. PubMed ID: 2536826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
    Chrisp CE; Sunstrum JC; Averill DR; Levine M; Glorioso JC
    Lab Invest; 1989 Jun; 60(6):822-30. PubMed ID: 2543866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands.
    Peles E; Rosen H; Darai G; Rösen-Wolff A; Becker Y
    Arch Virol; 1990; 113(3-4):151-63. PubMed ID: 2171454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two thymidine kinase deficient herpes simplex viruses exhibit unexpected virulence properties.
    Izumi KM; Stevens JG
    Microb Pathog; 1988 Feb; 4(2):145-53. PubMed ID: 2849029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological basis for virulence of three strains of herpes simplex virus type 1.
    Sedarati F; Stevens JG
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2389-95. PubMed ID: 2821178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain.
    Javier RT; Izumi KM; Stevens JG
    J Virol; 1988 Apr; 62(4):1381-7. PubMed ID: 2831400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the virulence genes of herpes simplex virus 2 by experimental infection in vivo with defined intertypic recombinants of a virulent HSV-2 X an avirulent HSV-1.
    Rösen A; Darai G
    Med Microbiol Immunol; 1985; 174(5):237-48. PubMed ID: 3003551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.
    McKendall RR; Klassen T; Baringer JR
    Infect Immun; 1979 Feb; 23(2):305-11. PubMed ID: 217828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinvasion by herpes simplex virus. An in vitro model for characterization of neurovirulent strains.
    Bergström T; Lycke E
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():405-10. PubMed ID: 2155294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea-pig neural tissues by 5-azacytidine.
    Stephanopoulos DE; Kappes JC; Bernstein DI
    J Gen Virol; 1988 May; 69 ( Pt 5)():1079-83. PubMed ID: 2453606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus.
    Leist TP; Sandri-Goldin RM; Stevens JG
    J Virol; 1989 Nov; 63(11):4976-8. PubMed ID: 2552180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.